Cover Image

Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.

BACKGROUND:Lymphatic filariasis (LF) is targeted for elimination by the year 2020. As of 2017, 67 of the 72 endemic countries have implemented annual Mass Drug Administration (MDA) for interrupting LF transmission. Transmission Assessment Survey (TAS) is the recommended protocol to evaluate the impa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Swaminathan Subramanian (Author), Purushothaman Jambulingam (Author), Kaliannagounder Krishnamoorthy (Author), Neelavathi Sivagnaname (Author), Candasamy Sadanandane (Author), Venkatesan Vasuki (Author), Chokkalingam Palaniswamy (Author), Balakrishnan Vijayakumar (Author), Adinarayanan Srividya (Author), Hari Kishan K Raju (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2020-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India.
by: Swaminathan Subramanian, et al.
Published: (2017)

Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
by: Subramanian Swaminathan, et al.
Published: (2012)

Molecular xenomonitoring of diurnally subperiodic Wuchereria bancrofti infection in Aedes (Downsiomyia) niveus (Ludlow, 1903) after nine rounds of Mass Drug Administration in Nancowry Islands, Andaman and Nicobar Islands, India.
by: Addepalli Premkumar, et al.
Published: (2020)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
by: Purushothaman Jambulingam, et al.
Published: (2021)

Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India.
by: Raja Jeyapal Dinesh, et al.
Published: (2023)

Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study
by: Muhammed Jabir, et al.
Published: (2024)

Development of an urban molecular xenomonitoring system for lymphatic filariasis in the Recife Metropolitan Region, Brazil.
by: Anita Ramesh, et al.
Published: (2018)

Lymphatic filariasis transmission on Mafia Islands, Tanzania: Evidence from xenomonitoring in mosquito vectors.
by: Yahya A Derua, et al.
Published: (2017)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame.
by: Colleen L Lau, et al.
Published: (2016)

Assessment of Culicidae collection methods for xenomonitoring lymphatic filariasis in malaria co-infection context in Burkina Faso.
by: Sanata Coulibaly, et al.
Published: (2024)

Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka.
by: Ramakrishna U Rao, et al.
Published: (2016)

Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa.
by: Mark A Schmaedick, et al.
Published: (2014)

Evaluation of the mtDNA-COII Region Based Species Specific Assay for Identifying Members of the Anopheles culicifacies Species Complex.
by: Arulsamy Mary Manonmani, et al.
Published: (2013)

Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
by: Dziedzom K de Souza, et al.
Published: (2020)

Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017)

The lymphatic filariasis treatment study landscape: A systematic review of study characteristics and the case for an individual participant data platform.
by: Luzia T Freitas, et al.
Published: (2024)

Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India - a cross sectional study
by: Raja Jeyapal Dinesh, et al.
Published: (2023)

Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
by: Pramod Kumar Mehta, et al.
Published: (2024)

Evaluating the diagnostic test accuracy of molecular xenomonitoring methods for characterising the community burden of Onchocerciasis.
by: Joseph Pryce, et al.
Published: (2021)

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
by: Charles W Goss, et al.
Published: (2019)

Modelling spatiotemporal patterns of visceral leishmaniasis incidence in two endemic states in India using environment, bioclimatic and demographic data, 2013-2022.
by: Swaminathan Subramanian, et al.
Published: (2024)

A Novel Xenomonitoring Technique Using Mosquito Excreta/Feces for the Detection of Filarial Parasites and Malaria.
by: Nils Pilotte, et al.
Published: (2016)

Illuminating the Prevalence of Trypanosoma brucei s.l. in Glossina Using LAMP as a Tool for Xenomonitoring.
by: Lucas J Cunningham, et al.
Published: (2016)

Filariasis in body fluids: Report of three cases
by: K Jayaprakash Shetty, et al.
Published: (2014)

Filariasis in body fluids: Report of three cases
by: K Jayaprakash Shetty, et al.
Published: (2014)

Caught in a trap: DNA contamination in tsetse xenomonitoring can lead to over-estimates of Trypanosoma brucei infection.
by: Isabel Saldanha, et al.
Published: (2024)

Molecular xenomonitoring for Wuchereria bancrofti in Culex quinquefasciatus in two districts in Bangladesh supports transmission assessment survey findings.
by: Seth R Irish, et al.
Published: (2018)

Comparison of collection methods for Phlebotomus argentipes sand flies to use in a molecular xenomonitoring system for the surveillance of visceral leishmaniasis.
by: Shannon McIntyre-Nolan, et al.
Published: (2023)

Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
by: Darin S Evans, et al.
Published: (2014)

Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA).
by: Benjamin S Collyer, et al.
Published: (2020)

PENYAKIT FILARIASIS
by: Masrizal Masrizal
Published: (2012)

Ultrasound guided erector spinae plane block -An effective rescue analgesia for pediatric open upper abdominal surgery
by: Aswini Kuberan, et al.
Published: (2021)

Evaluation of Filariasis "MDP" Implementation on Changing Aspects of Knowledge, Environment, and Behavior of Filariasis Sufferers
by: Irfan Irfan, et al.
Published: (2019)

Field laboratory comparison of STANDARD Q Filariasis Antigen Test (QFAT) with Bioline Filariasis Test Strip (FTS) for the detection of Lymphatic Filariasis in Samoa, 2023.
by: Jessica L Scott, et al.
Published: (2024)

AI sees an end to filariasis
by: Michael W. Gaunt, et al.
Published: (2024)

Lymphatic Filariasis in Sri Lanka
by: C. Harriet Gautamadasa
Published: (2001)

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015)

A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
by: Alison Krentel, et al.
Published: (2021)

A spatio-temporal approach to short-term prediction of visceral leishmaniasis diagnoses in India.
by: Emily S Nightingale, et al.
Published: (2020)

Impediments to compliance during filariasis mass drug administration-Observations and recommendations to accelerate filariasis elimination in India
by: Philip Raj Abraham, et al.
Published: (2024)